ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "physical function"

  • Abstract Number: 0140 • ACR Convergence 2020

    Meaningful Within-Patient Change in WOMAC Domains in Patients with Moderate-To- Severe Osteoarthritis

    Philip G Conaghan1, Robert Dworkin2, Thomas Schnitzer3, Francis Berenbaum4, Andrew Bushmakin5, Joseph Cappelleri5, Lars Viktrup6 and Lucy Abraham7, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research Leeds Biomedical Research Centre, Leeds, United Kingdom, 2University of Rochester School of Medicine and Dentistry, Rochester, NY, 3Northwestern University Feinberg School of Medicine, Chicago, IL, 4Sorbonne Universite�, Paris, France, 5Pfizer Inc, Groton, CT, 6Eli Lilly and Company, Indianapolis, IN, 7Pfizer Inc, Tadworth, United Kingdom

    Background/Purpose: The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a disease-specific measure of osteoarthritis (OA) symptoms (pain and stiffness) and functional impairment regularly…
  • Abstract Number: 1650 • ACR Convergence 2020

    A Double-Blind Randomized Trial to Evaluate the Efficacy of Corticosteroid Injections for Osteoarthritis of the Knee Using Mobile Devices

    Joshua Baker1, Mitesh Patel1, Tuhina Neogi2, Keith Robinson3, Alexis Ogdie1 and Carla Scanzello1, 1University of Pennsylvania, Philadelphia, PA, 2Boston University School of Medicine, Boston, MA, 3Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA

    Background/Purpose: The value of intra-articular (IA) corticosteroid injections for osteoarthritis of the knee (KOA) has recently been called into question.  Variability in clinical trial design…
  • Abstract Number: 0322 • ACR Convergence 2020

    Development and Preliminary Validation of Smartphone Sensor-based Measurement Tools for Psoriatic Arthritis

    Dan Webster1, Rebecca Haberman2, Lourdes Perez-Chada3, Stockard Simon4, Woody MacDuffie4, Michael DePhillips5, Soumya Reddy6, Alexis Ogdie7, Lara Mangravite4, Joseph Merola8 and Jose Scher2, 1Sage Bionetworks, Seattle, WA, 2NYU School of Medicine, New York City, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 4Sage Bionetworks, Seattle, 5SDP Digital, Seattle, 6NYU School of Medicine, New York, NY, 7University of Pennsylvania, Philadelphia, PA, 8Brigham and Women's Hospital, Harvard Medical School, Newton, MA

    Background/Purpose: The COVID-19 pandemic has increasingly driven clinical care into remote settings, where patients with immune-mediated and inflammatory diseases struggle to convey symptom severity to…
  • Abstract Number: 1728 • ACR Convergence 2020

    Patient-Reported Outcomes of Upadacitinib versus Abatacept in Patients with Rheumatoid Arthritis and an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: 12-Week Results of a Phase 3 Study

    Martin Bergman1, Jeffrey Enejosa2, Naomi Martin2, Jessica Suboticki2, Debbie Goldschmidt3, Yan Song3 and Namita Tundia2, 1Drexel University College of Medicine, Philadelphia, PA, 2AbbVie Inc., North Chicago, IL, 3Analysis Group, Inc., Boston, MA

    Background/Purpose: In patients with active rheumatoid arthritis (RA), treatment with upadacitinib (UPA) has resulted in clinically meaningful improvements in patient-reported outcomes (PROs). This post hoc…
  • Abstract Number: 0337 • ACR Convergence 2020

    Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function

    Anna-Maria Liphardt1, Eva Manger2, Sonja Liehr2, Lisa Bieniek2, Arnd Kleyer3, David Simon3, Koray Tascilar3, Michael Sticherling4, Juergen Rech3, Georg Schett5 and Axel Hueber6, 1Friedrich-Alexander-University Erlangen-Nuremberg, Internal Medicine 3 - Rheumatology & Immunology, University Hospital Erlangen, Erlangen, Bayern, Germany, 2Departement of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nuremberg and University Hospital Erlangen, Erlangen, Bayern, Germany, 3Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 4Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, 5Friedrich-Alexander-Universität Erlangen- Nuremberg, Erlangen, Germany, 6Sozialstiftung Bamberg, Sektion Rheumatologie, Bamberg, Germany

    Background/Purpose: To compare the impact of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) on objective and subjective parameters of hand function.Methods: Hand function was assessed…
  • Abstract Number: 0536 • ACR Convergence 2020

    Systematic Geriatric Assessment in Older Patients with Rheumatic Diseases – The RheuMAGIC Pilot Study

    Bjoern Buehring1, Anna Berrisch2, Ioana Andreica3, Styliani Tsiami4, David Kiefer3, Uta Kiltz2, Xenofon Baraliakos2 and Juergen Braun2, 1Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Velbert, Germany, 2Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany

    Background/Purpose: Current demographic data predict that the number of older adults with rheumatic diseases will considerably increase in the coming years. Geriatric patients differ from…
  • Abstract Number: 0551 • ACR Convergence 2020

    Physical Performance as a Mediator of the Association Between Depression and Pain in Knee Osteoarthritis

    Alan Rathbun1, Elizabeth Stuart2, Michelle Shardell1, Trang Nguyen2, Alice Ryan1, Joseph Gallo2, Michelle Yau3, Megan Schuler4 and Marc Hochberg1, 1University of Maryland School of Medicine, Baltimore, MD, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Hinda and Arthur Marcus Institute for Aging Research, Boston, MA, 4RAND Corporation, Boston, MA

    Background/Purpose: Depression is common in knee osteoarthritis (OA), and leads to reduced physical function, which may mediate the effect of depression on pain. However, research…
  • Abstract Number: 0744 • ACR Convergence 2020

    Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations with Disease Characteristics, Body Composition, and Physical Functioning

    Patrick Gould1, Babette Zemel2, Elena Taratuta3 and Joshua Baker1, 1University of Pennsylvania, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, 3University of Pennsylvania, Philadelphia

    Background/Purpose: Rheumatoid arthritis (RA) can lead to changes in body composition, including muscle loss and excess adiposity, which are in turn associated with physical disability.…
  • Abstract Number: 0931 • ACR Convergence 2020

    Oropharyngeal Dysfunction in Patients with Systemic Sclerosis – Results of a Monocentric Clinical Study

    Philipp Klemm1, Mirjam Wirths2, Ole Hudowenz2, Ulrike Hoffmann3, Ulf Müller-Ladner2 and Uwe Lange2, 1Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, Bad Nauheim, Hessen, Germany, 2Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, Bad Nauheim, Germany, 3Practice for Speech Therapy Ulrike Hoffmann, Friedberg, Germany

    Background/Purpose: Nearly 98% of patients with systemic sclerosis (SSc) are suffering from gastrointestinal involvement (Schmeiser et al. 2012). While in everyday clinical practice screening for…
  • Abstract Number: 1084 • ACR Convergence 2020

    Consumer-based Activity Trackers in Evaluation of Physical Function in Myositis Patients

    Didem Saygin1, Bonny Rockette-Wagner2, Chester Oddis3, Diane Koontz1, Siamak Moghadam-Kia1 and Rohit Aggarwal2, 1University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3Department of Medicine, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Idiopathic inflammatory myopathies are systemic inflammatory conditions characterized by muscle weakness and reduced muscle endurance that limit activities of daily living. Daily step count…
  • Abstract Number: 1375 • 2019 ACR/ARP Annual Meeting

    Patient-Reported Outcomes of Upadacitinib versus Adalimumab Use in Patients with Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate: 26-Week Analysis of a Phase 3 Study

    Roy Fleischmann1, Martin Bergman 2, Namita Tundia 3, In-Ho Song 4, Jessica Suboticki 4, Yan Song 5 and Vibeke Strand 6, 1Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX, 2Drexel University College of Medicine, Stockholm, Sweden, 3AbbVie Inc., North Chicago, IL, 4AbbVie Inc., North Chicago, IL, USA, North Chicago, IL, 5Analysis Group, Inc., Boston, MA, 6Division of Immunology/Rheumatology, Stanford University, Stanford, CA

    Background/Purpose: In patients with active rheumatoid arthritis (RA), 12-week treatment with upadacitinib (UPA) while on background MTX therapy resulted in significant and clinically meaningful improvements…
  • Abstract Number: 1376 • 2019 ACR/ARP Annual Meeting

    Impact of 24- or 26-Week Upadacitinib Monotherapy on Patient-Reported Outcomes in Patients with Moderately to Severely Active Rheumatoid Arthritis and No Prior Use of or an Inadequate Response to Methotrexate: Results from Two Phase 3 Trials

    Vibeke Strand1, Namita Tundia 2, Alan Friedman 3, Heidi Camp 2, Jessica Suboticki 4, Debbie Goldschmidt 5, Catherine Fernan 5 and Martin Bergman 6, 1Division of Immunology/Rheumatology, Stanford University, Stanford, CA, 2AbbVie Inc., North Chicago, IL, 3AbbVie Inc., North Chicago, 4AbbVie Inc., North Chicago, IL, USA, North Chicago, IL, 5Analysis Group, Inc., New York, NY, 6Drexel University College of Medicine, Stockholm, Sweden

    Background/Purpose: Treatment with upadacitinib (UPA) monotherapy, a selective Janus kinase-1 (JAK-1) inhibitor, resulted in significant and clinically meaningful improvements in patient-reported outcomes (PROs) at Week…
  • Abstract Number: 2089 • 2019 ACR/ARP Annual Meeting

    Restricting Activity to Evade Knee Symptoms Is Associated with Worse Physical Function and Radiographic Osteoarthritis

    Louise Thoma1, Jason Jakiela 2, Hiral Master 1, Dana Voinier 2, Meredith Christiansen 2 and Daniel White 1, 1University of Delaware, Newark, DE, 2University of Delaware, Newark

    Background/Purpose: Activity restriction (i.e. limiting or avoiding normal activity) is a common strategy to reduce, and sometimes eliminate, knee symptoms. Knee symptoms, such as pain,…
  • Abstract Number: 2160 • 2019 ACR/ARP Annual Meeting

    Myopenia Is an Independent Risk Factor for Rotator Cuff Tear and Shoulder Dysfunction in Elderly People : Data from NAMGARAM Cohort

    Yun-Hong Cheon1, Young Sun Suh 2, Mingyo Kim 1, Ki-Soo Park 3 and Sang-Il Lee 1, 1Divison of Rheumatology, Gyeongsang National University Hospital, Jin-Ju, Republic of Korea, 2Divison of Rheumatology, Gyeongsang National University Hospital, Changwon, Changwon, Republic of Korea, 3Preventive Medicine, Gyeongsang National University Hospital, Jin-Ju, Republic of Korea

    Background/Purpose: Myopenia refers to decline in muscle mass with age, causing significant impairment in the ability to carry out normal daily functions. Rotator cuff tear…
  • Abstract Number: 2174 • 2019 ACR/ARP Annual Meeting

    Test-Retest Reliability and Validity of a Mobile Health Application to Automate the 30 Seconds Chair Stand Test – Preliminary Data to Create a Contemporary Instrument for Randomized Clinical Trials

    Lucas Dantas1, Matthew Harkey 2, André Dantas 3, Lori Lyn Price 4, Jeffrey Driban 5 and Timothy McAlindon 1, 1Tufts Medical Center, Boston, MA, 2Tufts Medical Center, University of Massachusetts Medical School, Boston, MA, 3CI&T, Tokyo, Japan, 4Tufts Medical Center, Tufts University, Boston, MA, 5Tufts Medical Center, Boston

    Background/Purpose: Contemporary technologies offer potential solutions to improve and automate data collection of randomized clinical trials by transitioning assessments from the clinic to the real-world.…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology